American Herbal Products Association (AHPA) > News > AHPA in the News

AHPA in the News

Webinar: Adverse Event Reports (AERs) and Recalls of Dietary Supplements

In-depth review of AER requirements and recent AER and recall data and trends

Dr. Rick Kingston, an industry expert with more than 35-years of experience, presents on serious adverse event report (SAER) data and observations. Ashish Talati, a partner with Amin Talati & Wasserman and one of the industry’s foremost experts on FDA regulatory matters, joins Dr. Kingston to review dietary supplement legal and regulatory SAER obligations. In addition, AHPA Chief Information Officer Dr. Merle Zimmermann presents an overview of recent FDA recall data.

September 2019 AHPA in the News


Guidance: Federal Labeling Requirements for Herbal Dietary Supplements

Updated to reflect changes from May 2016 Final Rule revising FDA’s nutrition labeling regulations

AHPA has revised it's labeling guidance for herbal dietary supplements to cover updated nutrition labeling requirements for foods and dietary supplements that are scheduled to take effect January 1, 2020 for manufacturers with $10 million or more in annual sales and January 1, 2021 for smaller manufacturers.

AHPA presents at the AOAC INTERNATIONAL 133rd Annual Meeting & Exposition

Michael McGuffin and Holly Johnson, Ph.D. outline ways AOAC analytical methods can support the herbal supplement industry

AHPA President Michael McGuffin and Chief Science Officer Holly Johnson, Ph.D. presented at the AOAC International 133rd Annual Meeting and Exposition to help the organization further develop analytical methods for botanicals used in herbal supplements.

Online Sustainability Bootcamp -- Fall Session

Oct. 17 - Nov. 21 -- Discount for AHPA members

NSF offers a comprehensive 6-week online training program specifically designed for busy professionals in the food, supplements and beverage industries who aim to lead successful sustainability programs that positively impact their company and communities.
Dietary supplement recalls are relatively infrequent according to recent FDA data

Dietary supplement recalls are relatively infrequent according to recent FDA data

Two percent of more than 800 recalls initiated in 2019 involved dietary supplement products

Recall data from the Food and Drug Administration (FDA) shows that 14 of 803 (1.7 percent) recorded recalls initiated in 2019 involved dietary supplements, and among these, three were Class I recalls (the most serious recall class), according to an article published in the August 2019 AHPA Report.

August 2019 AHPA in the News

CO Gov Jared Polis charts course for CBD and hemp innovation at sold-out AHPA Supplement Congress

CO Gov Jared Polis charts course for CBD and hemp innovation at sold-out AHPA Supplement Congress

USDA and FDA officials share key information for companies selling hemp-CBD in dietary supplements

Colorado Governor Jared Polis rallied more than 200 hemp farmers, manufacturers, producers, retailers, and industry professionals during his keynote address to the American Herbal Products Association (AHPA) Hemp-CBD (cannabidiol) Supplement Congress held earlier this month.
ERB Foundation seeks matching funds to sponsor ginseng program at 2020 Smithsonian Folklife Festival

ERB Foundation seeks matching funds to sponsor ginseng program at 2020 Smithsonian Folklife Festival

June 24-28 and July 1-5, 2020 -- Washington, DC

The AHPA Foundation for Education and Research on Botanicals (AHPA ERB Foundation) has committed to provide financial support for the American ginseng program to be presented as part of the 2020 Smithsonian Folklife Festival, an annual 10-day event that takes place on the National Mall in Washington, D.C. The Foundation is seeking matching funds from AHPA members to increase the Foundation’s support of this program.

CA Prop 65 Guidance for Hemp Products

Regulatory and liability implications of Proposition 65 for hemp and hemp-derived products

AHPA has published Guidance on California Proposition 65 and Hemp Products to educate the hemp industry about the regulatory and liability implications of Proposition 65 for hemp and hemp-derived products, including cannabidiol (CBD), sold in the State of California.
RSS
123456

2019 Annual Fund Sponsors

  

AHPA appreciates the support of its sponsors, but does not endorse, recommend, or provide a warranty for any sponsor company, its products or services. AHPA has no responsibility for any transaction entered into with any of these companies.